Updated December 3, 2025 at 7:00 AM.

Intermedical Care and Lab Hospital Public Company Limited recognizes the importance of shareholders and good corporate governance. The Company is committed to ensuring that all shareholders are treated equitably.

Accordingly, the Company provides shareholders with the opportunity to participate by proposing matters they consider important and appropriate for inclusion in the agenda of the Company’s Annual General Meeting of Shareholders (AGM). In addition, shareholders may propose qualified individuals with appropriate knowledge, capability, and suitability for consideration as candidates for election as directors in advance of the AGM.

This process allows the Board of Directors to review and screen such proposals and to prepare for the inclusion of the proposed agenda items in the Company’s AGM accordingly.

Shareholders who wish to propose matters for inclusion in the agenda of a shareholders’ meeting, or to nominate individuals for consideration as directors of the Company, must collectively hold not less than five percent (5%) of the total voting rights of the Company as of the date of exercising such rights.

Please download the following details:

1. Criteria for Shareholders to propose AGM Agenda and Director Nominee In advance for the AGM of the year 2027

2. Criteria for shareholder to Submission of the Question
3. Form for Proposing Agenda in Advance for the AGM 2027

4. Form for Proposing Director Nominee for the AGM 2027

5. Information of Proposed Candidate for Director Position for the AGM 2027

6. From to Submission of the Question

The Audit Committee shall review and screen the proposals before submitting them to the Board of Directors for consideration as to whether they should be included in the agenda of the Annual General Meeting of Shareholders. The decision of the Board of Directors regarding such proposals shall be final.

The Company reserves the right to consider only those submissions that are complete, duly filled out, and accompanied by sufficient supporting documentation, and that have been properly submitted in accordance with these criteria. Such submissions must also be deemed beneficial to the Company and its shareholders as a whole, and must comply with all applicable laws and regulations.

Investor relations page